Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients (ERAMUNE-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01019551
Recruitment Status : Completed
First Posted : November 25, 2009
Last Update Posted : June 13, 2013
Sponsor:
Collaborators:
Cytheris SA
Merck Sharp & Dohme Corp.
Pfizer
Information provided by (Responsible Party):
Objectif Recherche Vaccins SIDA

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2012
Actual Study Completion Date : February 2013